Head-to-head · WeighScore
Boston Medical Group vs Vitalex Health
The verdict
Boston Medical Group takes it — 61.9/100 to 59.7/100.
Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Boston Medical Group is an established medical group running a 12-week compounded GLP-1 weight-loss programme.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Boston Medical Group | Vitalex Health |
|---|---|---|
| WeighScore | 61.9/100 | 59.7/100 |
| Grade | C | C |
| Scorecard rank | #279 | #337 |
| Semaglutide | $199/mo (starting strength, rising with dose, compounded) | $199/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $199/mo (starting dose, compounded) |
| Coverage | 7 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #279 · C
Strengths
- An established medical group with a defined 12-week programme rather than an open-ended subscription
- The price range and the 12-week total are both published, once you reach the costs page
- Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight
Where it loses points
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week programme totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
- The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
- Semaglutide and tirzepatide are not priced separately — one range covers the whole programme
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #337 · C
Strengths
- Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
- Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
- Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
- Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
- Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links
Where it loses points
- Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
- No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
- Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
- Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
- Domain was registered in April 2026 — a brand-new practice with no independent reviews found
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.